| GI50 | 50% growth inhibition concentration |
| HDAC | Histone deacetylase |
| PARP | Poly(ADP-ribose) polymerase 1 |
| TLR4 | Toll-like receptor 4 |
| COX-2 | Cyclooxygenase-2 |
| LPS | Lipopolysaccharide |
| C. albicans | Candida albicans |
| E. coli | Escherichia coli |
| P. aeruginosa | Pseudomonas aeruginosa |
| S. aureus | Staphylococcus aureus |
| S. cerevisiae | Saccharomyces cerevisiae |
| S. pyogenes | Streptococcus pyogenes |
| ABTS | 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) |
| AChE | Acetylcholinesterase |
| BuChE | Butyrylcholinesterase |
| K. pneumoniae | Klebsiella pneumoniae |
| DPPH | 2,2-Diphenyl-1-picrylhydrazyl |
| FRAP | Ferric Reducing Antioxidant Power |
| NAFLD | Non-alcoholic fatty liver disease |
| PPARγ | Peroxisome Proliferator-Activated Receptor gamma |
| iNOS | Inducible nitric oxide synthase |